Rayana AI
Account
MRK
HOLD / NEUTRALMeanRev
Composite
53.30
Technical
82.90
Fundamental
43.50
Rank
Price
135.17
Hurst
0.37
As of
Aug 19, 2026
Daily
Merck & Co., Inc.
HealthcareDrug Manufacturers - General

Merck & Co., Inc. is a global pharmaceutical and healthcare company that develops and markets human medicines for oncology, infectious disease, vaccines, and other therapeutic areas, along with veterinary pharmaceuticals and animal health solutions across livestock and companion animal segments. The company operates through partnerships and licensing agreements with various biotech and pharmaceutical firms to expand its portfolio of cancer treatments, immunotherapies, and other drug candidates. Founded in 1891 and headquartered in New Jersey, Merck operates worldwide across human health, animal health, and healthcare services.

Market cap
$363.0B
P/E (trailing)
115.87
P/E (forward)
15.41
PEG ratio
2.65
Dividend yield
235.00%
Beta
0.23
52w range
77.58 – 156.92
Return on equity
+6.96%
Profit margin
+4.77%
Revenue growth
+5.10%
Earnings growth
Price history

1Y: 144.91 (+83.0%) · range 75.39–155.53

Cycle position
60/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 7 · NOT READY · exit proximity 0

Conviction
17/ 100 · maturity 100%
VScore.409
Buildup.2028
EMA entry setup.257
Fundamentals.1544
Volume profile
POC
118.88
Price vs POC
+21.9%
Overhead supply
16%
Runway
open sky

Value area 109.47129.27 · 16% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
earnings-surprise
0.033
Sep 2, 2026
Forward returns
HorizonReturnMFEState
20d-3.05%-0.63%3/20d
40d-3.05%-0.63%3/40d